ArticleCureus2025
Spindle Cell Rhabdomyosarcoma of the Hand in a Full-Term Newborn: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhabdomyosarcoma (RMS) is a rare soft tissue tumor with the most common sites of origin in the genitourinary tract, head, and neck regions, and extremities are less commonly involved. Spindle cell RMS is a rare variant of RMS in infants. RMS is uncommon in the hand. We present a case of spindle cell RMS in the hand of a full-term female newborn with regional lymph node involvement. Based on histopathology, the diagnosis of spindle cell RMS was made in stage IRS 3 of the Intergroup Rhabdomyosarcoma Study Group (IRSG) staging system. The infant underwent complete surgical resection and axillary lymph node removal, followed by chemotherapy. She died from complications of chemotherapy a year after initiation of treatment. The age, gender, poor outcome, and site are unusual features for this type of RMS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.